Application Nr Approved Date Route Status External Links
ANDA088262 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Depression: For The Relief Of Symptoms Of Depression. Endogenous Depression Is More Likely To Be Alleviated Than Other Depressive States. One To Three Weeks Of Treatment May Be Needed Before Optimal Therapeutic Effects Are Evident. Childhood Enuresis: May Be Useful As Temporary Adjunctive Therapy In Reducing Enuresis In Children Aged 6 Years And Older, After Possible Organic Causes Have Been Excludedby Appropriate Tests. In Patients Having Daytime Symptoms Of Frequency And Urgency, Examination Should Include Voiding Cystourethrography And Cystoscopy, As Necessary. The Effectiveness Of Treatment May Decrease With Continued Drug Administration.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Imipramine Hydrochloride IMIPRAMINE HYDROCHLORIDE ZINC20245

Comments